PT  - JOURNAL ARTICLE
AU  - Domingues, Tiago Dias
AU  - Mouriño, Helena
AU  - Sepúlveda, Nuno
TI  - Analysis of cutoff point estimation for determining seropositivity in the context of SARS-CoV-2 infections
AID  - 10.1101/2021.12.20.21268100
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.20.21268100
4099  - http://medrxiv.org/content/early/2021/12/22/2021.12.20.21268100.short
4100  - http://medrxiv.org/content/early/2021/12/22/2021.12.20.21268100.full
AB  - In this work will apply mixture models based on distributions from the SMSN family to antibody data against four SARS-CoV-2 virus antigens. Furthermore, since the true infection status of individuals is known a priori, performance measures will be calculated for the methods proposed for cutoff point estimation such as sensitivity, specificity and accuracy. The results of a simulation study will also be presented.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded by FCT - Fundacao para a Ciencia e a Tecnologia, Portugal, through the project UIDB/00006/2020Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/MWhite-InstitutPasteur/SARSCoV2SeroDXphase2 https://github.com/MWhite-InstitutPasteur/SARSCoV2SeroDXphase2